FDA.reportPublic FDA data

avatrombopag 20 MG Oral Tablet [Doptelet]

RxCUI
2045958
RxNorm name
avatrombopag 20 MG Oral Tablet [Doptelet]
Display name
avatrombopag 20 MG Oral Tablet [Doptelet]
Full name
avatrombopag 20 MG Oral Tablet [Doptelet]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Doptelet SprinkleAVATROMBOPAGAkaRx, Inc.e2d5960d-6c18-46cc-86bd-089222b098522025-08-13Warnings, Adverse reactionsExact identifier
rxcui: 2045958

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e2d5960d-6c18-46cc-86bd-089222b09852Doptelet 20 MG Oral Tablet [PSN] · avatrombopag 20 MG Oral Tablet [Doptelet] [SBD] · Doptelet 20 MG Oral Tablet [SY]321These highlights do not include all the information needed to use DOPTELET safely and effectively. See full prescribing information for DOPTELET. DOPTELET ® (avatrombopag ) tablets, for oral use DOPTELET® SPRINKLE (avatrombopag) oral granules Initial U.S. Approval: 201820250813